ReShape Lifesciences Inc.
RSLS
$0.63
-$0.0055-0.87%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 0.88% | 27.27% | -29.15% | 51.95% | -1.17% |
| Total Depreciation and Amortization | -16.67% | 0.00% | -14.29% | -86.00% | 2.04% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,107.69% | 92.33% | -6,680.00% | -100.54% | 938.18% |
| Change in Net Operating Assets | 288.76% | -43.17% | 159.66% | -249.08% | 92.99% |
| Cash from Operations | 77.08% | 34.51% | 15.67% | 11.62% | 58.27% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 200.00% | -- |
| Cash from Financing | -100.00% | -- | -- | 1,715.68% | -115.02% |
| Foreign Exchange rate Adjustments | -85.71% | 187.50% | -233.33% | -- | 100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 76.62% | 36.25% | -169.10% | 196.54% | 29.39% |
